Hematology/Oncology

• Cover Stories

• Whole-genome sequencing yields knowledge, hope for future of cancer care

• HemOnc Today, February 25, 2013
• Compared with other disciplines of scientific discovery, cancer genomics is in its infancy.
  However, emerging data from comprehensive cancer genome...More »

• US cancer screening rates drop

• HemOnc Today, February 25, 2013
• Cancer screening rates declined in the United States during the past decade, and levels are less than optimal for many types of malignancies, according to...More »

• Perspective

• Ramucirumab increased survival among patients with advanced gastric cancer

• HemOnc Today, February 25, 2013
• The novel drug ramucirumab significantly improved survival compared with placebo among patients with metastatic refractory gastric or gastroesophageal...More »

• In the Journals

• Gadoxetic acid-enhanced magnetic resonance improved diagnosis of HCC in small nodules

• January 30, 2013
• The use of gadoxetic acid as a contrast agent for magnetic resonance can improve the sensitivity of hepatocellular carcinoma diagnosis in patients with...More »

• In the Journals

• Low plasma adiponectin levels linked to pancreatic cancer

• HemOnc Today, May 10, 2013
• Patients with low levels of circulating adiponectin are at an increased risk for developing pancreatic cancer, according to recent results.
  In a nested...More »

• Meeting News Coverage Perspective

• Gene expression profiling may help guide pancreatic cancer treatment

• HemOnc Today, February 25, 2013
• Pharmacogenomic profiling of circulating tumor cells in the bloodstream may help personalize the choice of chemotherapy for patients with pancreatic...More »

• Meeting News Coverage Perspective

• Docetaxel extended OS for patients with relapsed esophageal, stomach cancers

• HemOnc Today, March 10, 2013
• Second-line treatment with docetaxel significantly improved OS among patients with advanced esophago-gastric cancer, according to results of a phase 3...More »

• FDA approvals

• FDA approves Avastin plus chemotherapy regimen for mCRC

• HemOnc Today, February 25, 2013
• The FDA has approved the use of bevacizumab combined with chemotherapy for patients with metastatic colorectal cancer whose disease progressed after...More »

• Meeting News Coverage Perspective

• Oral agent improved OS in Japanese patients with pancreatic cancer

• HemOnc Today, February 25, 2013
• Adjuvant treatment with the chemotherapy drug S-1 increased OS among Japanese patients with pancreatic cancer, according to results of a phase 3 trial...More »

• In the Journals

• Shorter surveillance periods detected smaller HCC in patients with viral hepatitis

• January 24, 2013
• Hepatocellular carcinoma ultrasonography surveillance conducted at 4-month intervals resulted in greater detection of smaller tumors among viral hepatitis...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!